Abstract:Background: Glioblastoma is the most common type of brain cancer, with a prognosis that is unfortunately poor. Despite considerable progress in the field, the intricate molecular basis of this cancer remains elusive. Aim: The aim of this study was to identify genetic indicators of glioblastoma and reveal the processes behind its development. Objective: The advent and integration of supercomputing technology have led to a significant advancement in gene expression analysis platforms. Microarray analysis has gained recognition for its pivotal role in oncology, crucial for the molecular categorization of tumors, diagnosis, prognosis, stratification of patients, forecasting tumor responses, and pinpointing new targets for drug discovery. Numerous databases dedicated to cancer research, including the Gene Expression Omnibus (GEO) database, have been established. Identifying differentially expressed genes (DEGs) and key genes deepens our understanding of the initiation of glioblastoma, potentially unveiling novel markers for diagnosis and prognosis, as well as targets for the treatment of glioblastoma. Methods: This research sought to discover genes implicated in the development and progression of glioblastoma by analyzing microarray datasets GSE13276, GSE14805, and GSE109857 from the GEO database. DEGs were identified, and a function enrichment analysis was performed. Additionally, a protein-protein interaction network (PPI) was constructed, followed by module analysis using the tools STRING and Cytoscape. Results: The analysis yielded 88 DEGs, consisting of 66 upregulated and 22 downregulated genes. These genes' functions and pathways primarily involved microtubule activity, mitotic cytokinesis, cerebral cortex development, localization of proteins to the kinetochore, and the condensation of chromosomes during mitosis. A group of 27 pivotal genes was pinpointed, with biological process analysis indicating significant enrichment in activities, such as division of the nucleus during mitosis, cell division, maintaining cohesion between sister chromatids, segregation of sister chromatids during mitosis, and cytokinesis. The survival analysis indicated that certain genes, including PCNA clamp-associated factor (PCLAF), ribonucleoside- diphosphate reductase subunit M2 (RRM2), nucleolar and spindle-associated protein 1 (NUSAP1), and kinesin family member 23 (KIF23), could be instrumental in the development, invasion, or recurrence of glioblastoma. Conclusion: The identification of DEGs and key genes in this study advances our comprehension of the molecular pathways that contribute to the oncogenesis and progression of glioblastoma. This research provides valuable insights into potential diagnostic and therapeutic targets for glioblastoma.

Finding the specific markers of high and low grade gliomas with cDNA, Oiigo microarray with meta-analysis

Analysis of Differentially Expressed Genes Based on Microarray Data of Glioma.

Identification of Novel Human Glioblastoma-Specific Transcripts by Serial Analysis of Gene Expression Data Mining

Expression and Function of Differentially Expressed Genes in Glioblas-Toma by Using Cdna Microarray

Isolation of Novel Differentially Expressed Genes Related to Human Glioma Using CDNA Microarray and Characterizations of Two Novel Full-length Genes

Cluster Analysis of Gene Expression and Glioblastoma-Associated Gene by Using Cdna Microarray

Investigation gene and microRNA expression in glioblastoma

Bioinformatics Analysis Screening and Identification of Key Biomarkers and Drug Targets in Human Glioblastoma

Integrative analysis of genomic and epigenomic regulation reveals miRNA mediated tumor heterogeneity and immune evasion in lower grade glioma

Prognostic Markers Identification in Glioma by Gene Expression Profile Analysis

Gene Expression Profiling of Glioblastoma to Recognize Potential Biomarker Candidates

Differential gene expression analysis in glioblastoma cells and normal human brain cells based on GEO database

Malaria and blood transfusions.

Gene Expression and Cluster Analysis of Astrocytoma by Using Cdna Microarray

Cdna Microarray in Isolation of Novel Differentially Expressed Genes Related to Human Glioma and Clone of a Novel Full-Length Gene.

Identification of WHO II/III Gliomas by 16 Prognostic-related Gene Signatures using Machine Learning Methods

Comprehensive analysis of microglia gene and subpathway signatures for glioma prognosis and drug screening: linking microglia to glioma

Isolation of one novel full-length gene related to human giioma and its expression in vitro

Identification of novel prognostic targets in glioblastoma using bioinformatics analysis

Integrated Analysis of Mutations, Mirna and Mrna Expression in Glioblastoma.

Identification of robust diagnostic and prognostic gene signatures in different grades of gliomas: a retrospective study